CD73 mediates adhesion of B cells to follicular dendritic cells

被引:46
|
作者
Airas, L [1 ]
Jalkanen, S [1 ]
机构
[1] UNIV TURKU,NATL PUBL HLTH INST,TURKU,FINLAND
关键词
D O I
10.1182/blood.V88.5.1755.bloodjournal8851755
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lymphocyte-vascular adhesion protein-2 was recently identified as CD73. The CD73 molecule, otherwise known as ecto-5'-nucleotidase, is a lymphocyte maturation marker that is involved in intracellular signaling, and lymphocyte proliferation and activation. We now show that CD73, in addition to mediating lymphocyte binding to endothelial cells, also mediates adhesion between B cells and follicular dendritic cells (FDC), as a monoclonal antibody (MoAb) against CD73 inhibited the aggregation of isolated germinal center B cells and FDC in vitro. Cytocentrifuge preparations of isolated germinal center cells and two-color immunofluorescence stainings of different tonsillar B-cell populations show that CD73 is expressed on FDC and on small, recirculating IgD(+) B cells, but only on a few B cells inside the germinal center, Thus, we propose that CD73 on FDC has an important role in controlling B cell-FDC interactions and B-cell maturation in germinal centers. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:1755 / 1764
页数:10
相关论文
共 50 条
  • [21] MAb clusters reacting with B cells and follicular dendritic cells
    Hardie, DL
    Hill, D
    Casamayor, M
    Johnson, GD
    Khan, M
    MacLennan, ICM
    TISSUE ANTIGENS, 1996, 48 (4-II): : BC201 - BC201
  • [22] CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells
    Katsuta, Eriko
    Tanaka, Shinji
    Mogushi, Kaoru
    Shimada, Shu
    Akiyama, Yoshimitsu
    Aihara, Arihiro
    Matsumura, Satoshi
    Mitsunori, Yusuke
    Ban, Daisuke
    Ochiai, Takanori
    Kudo, Atsushi
    Fukamachi, Hiroshi
    Tanaka, Hiroshi
    Nakayama, Koh
    Arii, Shigeki
    Tanabe, Minoru
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (02) : 657 - 669
  • [23] CD73 conjugated microspheres as targeting vehicles for mesenchymal stem cells
    Ansboro, S.
    Greiser, U.
    Hayes, J.
    Barron, V.
    Brown, S.
    Pandit, A.
    Murphy, M.
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2012, 6 : 58 - 58
  • [24] CD73: A therapeutic target for pancreatic neuroendocrine tumor stem cells
    Katsuta, Eriko
    Tanaka, Shinji
    Mogushi, Kaoru
    Shimada, Shu
    Akiyama, Yoshimitsu
    Aihara, Arihiro
    Matsumura, Satoshi
    Mitsunori, Yusuke
    Ban, Daisuke
    Ochiai, Takanori
    Kudo, Atsushi
    Fulcamachi, Hiroshi
    Tanaka, Hiroshi
    Nakayama, Koh
    Arii, Shigeki
    Tanabe, Minoru
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S5 - S5
  • [25] Roles of the Adenosine Receptor and CD73 in the Regulatory Effect of γδ T Cells
    Liang, Dongchun
    Zuo, Aijun
    Shao, Hui
    Chen, Mingjiazi
    Kaplan, Henry J.
    Sun, Deming
    PLOS ONE, 2014, 9 (09):
  • [26] CD73 IS INVOLVED IN LYMPHOCYTE BINDING TO THE ENDOTHELIUM - CHARACTERIZATION OF LYMPHOCYTE VASCULAR ADHESION PROTEIN-2 IDENTIFIES IT AS CD73
    AIRAS, L
    HELLMAN, J
    SALMI, M
    BONO, P
    PUURUNEN, T
    SMITH, DJ
    JALKANEN, S
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05): : 1603 - 1608
  • [27] DYSREGULATED BALANCE OF CD39 AND CD73 CELLS IN DIABETIC ESRD PATIENTS
    Jo, Young-Il
    Seo, Eun-Hye
    Kim, Joo-Dong
    Lee, Seung-Hyun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 173 - 173
  • [28] Natural killer cells acquire CD73 expression upon exposure to mesenchymal stem cells
    Chatterjee, Debanjana
    Tufa, Dejene Milkessa
    Baehre, Heike
    Hass, Ralf
    Schmidt, Reinhold Ernst
    Jacobs, Roland
    BLOOD, 2014, 123 (04) : 594 - 595
  • [29] A possible role for LFA-1, CD39 and CD73 in regulatory T and B cells in psoriasis
    Terras, Sarah
    Mollet, Ilse
    Dullaers, Melissa
    van Geel, Nanja
    Lambert, Jo
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S14 - S14
  • [30] The expression of CD73 on pathological B-cells is associated with shorter overall survival of patients with CLL
    Kicova, M.
    Michalova, Z.
    Coma, M.
    Gabzdilova, J.
    Dedinska, K.
    Guman, T.
    Bernatova, S.
    Hajikova, M.
    Giertlova, M.
    Veselinyova, D.
    Sarissky, M.
    NEOPLASMA, 2020, 67 (04) : 933 - 938